Saturday, October 3, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleUk· December 10, 2025

FTSE 100 LIVE: Stocks mixed as traders await US Federal Reserve interest rate decision

View original at uk.finance.yahoo.com
FTSE 100 LIVE: Stocks mixed as traders await US Federal Reserve interest rate decision The FTSE 100 (^FTSE) pushed higher on Wednesday morning while European stocks were mixed as traders awaited the latest decision on interest rates from the Federal Reserve…
Opening lines of the source · Uk · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The announcement of the November budget and potential changes to stamp duty and council tax caused would-be buyers to wait

    80% confidence

  • There will be dissents in both a hawkish and dovish direction, and the statement and press conference will signal that the hurdle is relatively high for another cut in early 2026

    80% confidence

  • On track to meet pre-tax profit guidance of £450m for the year

    80% confidence

  • A December rate cut was not a foregone conclusion – far from it

    80% confidence

  • Oracle may not have substantial weight in the S&P 500 or NAS100 to move the index on its own, but what they detail on capex intentions and future funding plans could resonate across the AI space

    80% confidence

  • A range of factors are pushing up silver including a shortage fear as demand rises

    80% confidence

  • The group is expanding its use of artificial intelligence, which is a great opportunity

    80% confidence

  • Early signs are positive for summer 2026, with booked revenue well ahead in what remains a challenging operating environment

    80% confidence

  • When interest rates are cut, that naturally shifts demand toward assets viewed as stores of value, including silver

    80% confidence

  • Earnings are set to grow between 7% to 10% over the year ahead, while revenues are expected to rise by a slower 2% to 4%

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com